MicroRNA-181 as a prognostic biomarker for survival in acute myeloid leukemia: a meta-analysis

Accumulating evidence has indicated that microRNA-181 (miR-181) is dysregulated in hematological malignancies, and associates with the clinical outcomes. However, the association of miR-181 expression levels with acute myeloid leukemia (AML) remains inconclusive, as publications from different group...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Qiang, Luan, Junwen, Li, Ni, Zhang, Zhen, Zhu, Xiaoxiao, Zhao, Lin, Wei, Ran, Sun, Linlin, Shi, Yin, Yin, Xunqiang, Ding, Na, Jiang, Guosheng, Li, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687675/
https://www.ncbi.nlm.nih.gov/pubmed/29179505
http://dx.doi.org/10.18632/oncotarget.19195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687675/
https://www.ncbi.nlm.nih.gov/pubmed/29179505
http://dx.doi.org/10.18632/oncotarget.19195

Ejemplares similares